Efficacy of plant-produced recombinant antibodies against HCG

Human Reproduction

Volumn 17, Issue 8, 2002, Pages 2054-2061

  Kathuria, S ^a,b   Sriraman, R ^a,b   Nath, R ^a,b   Sack, M ^a   Pal, R ^c   Artsaenko, O ^a,e   Talwar, G P ^b   Fischer, R ^d   Finnern, R ^d  

^a Department of Molecular Biotechnology ^*  (Germany)

^b Talwar Research Foundation   (India)

^c NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^d FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antibody engineering; HCG; Plant expression system; Recombinant antibodies

Indexed keywords

CHORIONIC GONADOTROPIN ANTIBODY; RECOMBINANT CHORIONIC GONADOTROPIN ANTIBODY; TESTOSTERONE; UNCLASSIFIED DRUG; CHORIONIC GONADOTROPIN BETA SUBUNIT; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY ENGINEERING; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BETA CHAIN; CANCER; CANCER THERAPY; CONTRACEPTION; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG EFFICACY; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRESH WEIGHT; IN VITRO STUDY; LEYDIG CELL; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PHARMACOLOGICAL BLOCKING; PLANT LEAF; PREGNANCY TEST; PROTEIN ANALYSIS; TESTOSTERONE SYNTHESIS; TOBACCO; UTERUS WEIGHT; ANIMAL; BIOMEDICAL ENGINEERING; BIOSYNTHESIS; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG STABILITY; HISTOLOGY; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; MOUSE STRAIN; ORGAN SIZE; SERODIAGNOSIS; UTERUS;

ANIMALIA; NICOTIANA TABACUM;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; BIOMEDICAL ENGINEERING; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DRUG STABILITY; FEMALE; LEYDIG CELLS; MALE; MICE; MICE, INBRED STRAINS; NEUTRALIZATION TESTS; ORGAN SIZE; RECOMBINANT PROTEINS; TESTOSTERONE; TOBACCO; UTERUS;

EID: 0035988504     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.8.2054     Document Type: Article

References (42)

1. Metastatic phenotype correlates with high expression of membrane-associated complete beta-human chorionic gonadotropin in vivo
2. Detection of membrane-associated human chorionic gonadotropin and its subunits on human cultured cancer cells of the nervous system
3. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single chain Fv
4. Human chorionic gonadotropin as a model for a fetal antigen
5. Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia
6. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
7. Monoclonal antibodies to human chorionic gonadotropin (HCG) and their use in two-site binding enzyme immunoassays
8. The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti- apoptosis effect and not cell proliferation
9. Plant and mammalian sorting signals for protein retention in the endoplasmic reticulum contain a conserved epitope
10. Development of monoclonal antibodies directed against different epitopes of human chorionic gonadotropin
11. Molecular farming of pharmaceutical proteins
12. Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro
13. Development of hybridomas secreting anti-human chorionic gonadotropin antibodies
14. Frequent expression of beta-human chorionic gonadotropin (beta-hCG) in squamous cell carcinoma of the cervix
15. Value of HAMA-determination in clinical practice-an overview
16. Production of antibodies in transgenic plants
17. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent
18. Diabodies: Small bivalent and bispecific antibody fragments
19. High avidity scFv multimers diabodies and triabodies
20. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
21. Medical applications of single-chain antibodies
22. An Agrobacterium mediated transient gene expression system for intact leaves
23. Immunohistochemical expression of beta-human chorionic gonadotropin in colorectal carcinoma
24. hCG and the free beta-subunit as screening tests for Down syndrome
25. Plant antibodies for immunotherapy
26. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans
27. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
28. Plants as bioreactors for biopharmaceuticals: Regulatory considerations
29. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49
30. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains
31. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity
32. Human chorionic gonadotropin beta-core fragment is directly produced by cancer cells
33. Bioneutralization capacity of the antibodies generated in women by the beta subunit of human chorionic gonadotropin (beta hCG) and beta hCG associated with the alpha subunit of ovine luteinizing hormone linked to carriers
34. Immunological cross-reactivity of antibodies with species chorionic gonadotropin is a critical requirement for efficacy testing of human gonadotropin vaccines in sub-human primates
35. A vaccine that prevents pregnancy in women
36. An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations
37. Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: I. v. vs. i. p
38. Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves
39. Reduced virus infectivity in N. tabacum secreting a TMV-specific full-size antibody
40. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability
41. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes
42. GST fusion proteins cause false positives during selection of viral movement protein specific single chain antibodies